These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2893527)

  • 1. Intravenous fenoldopam in heart failure: comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprusside.
    Young JB; Leon CA; Pratt CM; Kingry C; Taylor AA; Roberts R
    Am Heart J; 1988 Feb; 115(2):378-84. PubMed ID: 2893527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure.
    Francis GS; Wilson BC; Rector TS
    Am Heart J; 1988 Aug; 116(2 Pt 1):473-9. PubMed ID: 2899970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hemodynamic tolerance from a 24-hour intravenous infusion of fenoldopam mesylate in congestive heart failure.
    Munger MA; Benotti JR; Green JA; Jarvis RC; Nara AR; McCue JE; Pospisil RA; Kasmer RJ
    Am J Cardiol; 1990 Jan; 65(3):206-10. PubMed ID: 1967511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension.
    Bednarczyk EM; White WB; Munger MA; Gonzalez FM; Panacek EA; Weed SG; Rutherford WF; Nara AR; Green JA
    Am J Cardiol; 1989 Apr; 63(13):993-6. PubMed ID: 2564726
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic correlates of left ventricular versus right ventricular radionuclide volumetric responses to vasodilator therapy in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
    Konstam MA; Weiland DS; Conlon TP; Martin TT; Cohen SR; Eichhorn EJ; Isner JM; Zile MR; Salem DN
    Am J Cardiol; 1987 May; 59(12):1131-7. PubMed ID: 3578055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of an oral dopamine receptor agonist (fenoldopam) in patients with congestive heart failure.
    Young JB; Leon CA; Pratt CM; Suarez JM; Aronoff RD; Roberts R
    J Am Coll Cardiol; 1985 Oct; 6(4):792-6. PubMed ID: 2863295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension.
    White WB; Halley SE
    Arch Intern Med; 1989 Apr; 149(4):870-4. PubMed ID: 2565105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery.
    Pomer S; Elert O; Sarai K; Satter P
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):77-81. PubMed ID: 3957495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous fenoldopam infusion in severe heart failure.
    Patel JJ; Mitha AS; Sareli P; de Vaal JB
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):97-101. PubMed ID: 8097927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure.
    Elkayam U; Weber L; Torkan B; McKay CR; Rahimtoola SH
    Am J Cardiol; 1984 May; 53(9):1321-5. PubMed ID: 6711434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
    Dei Cas L; Fappani A; Riva S; Metra M; Cicogna R; Manca C; Visioli O
    Clin Cardiol; 1985 Aug; 8(8):427-32. PubMed ID: 4028536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension.
    Reisin E; Huth MM; Nguyen BP; Weed SG; Gonzalez FM
    Hypertension; 1990 Feb; 15(2 Suppl):I59-62. PubMed ID: 1967592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of fenoldopam on systemic and regional hemodynamics in rabbits with congestive heart failure.
    Jover BF; McGrath BP
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):483-8. PubMed ID: 2453754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of vasodilator therapy in patients with severe congestive heart failure: limitations of measurements of left ventricular ejection fraction and volumes.
    Firth BG; Dehmer GJ; Markham RV; Willerson JT; Hillis LD
    Am J Cardiol; 1982 Nov; 50(5):954-9. PubMed ID: 6291370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of fenoldopam mesylate and nitroprusside on left ventricular performance in severe systemic hypertension.
    Hackman BB; Griffin B; Mills M; Ramanathan KB
    Am J Cardiol; 1992 Apr; 69(9):918-22. PubMed ID: 1347965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
    Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.
    Elliott WJ; Weber RR; Nelson KS; Oliner CM; Fumo MT; Gretler DD; McCray GR; Murphy MB
    Circulation; 1990 Mar; 81(3):970-7. PubMed ID: 1968368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics.
    Allison NL; Dubb JW; Ziemniak JA; Alexander F; Stote RM
    Clin Pharmacol Ther; 1987 Mar; 41(3):282-8. PubMed ID: 2880688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fenoldopam on renal blood flow and systemic hemodynamics during isoflurane anesthesia.
    Aronson S; Goldberg LI; Glock D; Roth S; Moss J; Roizen MF
    J Cardiothorac Vasc Anesth; 1991 Feb; 5(1):29-32. PubMed ID: 1678284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.